Unlimited Hangout and Michael McKibben took it from we left it and did such an top-class job just where we got stuck!
So I don’t want keep your attention for ourselves too long… Everything we hinted or expected got confirmed, and much more. I don’t vouch for every little detail in their work, just for about 99% of it and the general conclusion, that I also suggested in my previous work, but I missed the hard evidence.

Schwab Genealogy & History

Schwab is a locational German name, first given to someone who lived in the medieval dukedom of Swabia in southwest Germany, now Bavaria. This region took its name from the first century BCE Germanic tribe given the Latin name Suebi or Suevi. Schwab family history was first recorded in Franconia and Mecklenburg and includes Ulrich Schwab, the first Count of Nemerow. Variations on the spelling include Schwab, Schwebel, and Swab. American Schwab genealogy began around 1700 in Pennsylvania and includes financier Charles Schwab.

However, many Jews settled in Swabia and took the name, that’s why it’s erroneously perceived as a Jewish name in some areas.
That also played a historical role in an event that now shapes our lives.
A certain Jewish woman got involved with Schwabs that eventually came out as Nazi collaborators and Holocaust profiteers. And Klaus came to be…

Read here (where all the links and references are)

Listen here:

Audio version courtesy of:
Audioboy – Truth Audiobooks@audioboy

Please consider supporting his channel, thank you✊✊✊

… AND THEN IT GOT EVEN DEEPER

Michael McKibben of Leader Technologies and his group of researchers have done a DEEP dive into the history and the lineage of the World Economic Forum’s Klaus Schwab. He shares their shocking discoveries in this audio, with AIM4Truth’s Douglas Gabriel.

DOWNLOAD PDF PRESENTATION

Excerpts:

WEF IS A INSIDER TRADING FRAUD CIRCUS BARKED BY SCHWAB

Our discoveries about Klaus Schwab should prove beyond question that WEF is utterly fraudulent and an enemy of all humanity.

WEF meets every year in early February in Davos, Switzerland to map out their dystopic plans. We will show below that they are criminal, inhuman frauds. We will also show that Klaus Schwab is a sociopath with pathological mommy issues.

We have learned with these corruptocrat biographies that the information they hide is always highly instructive to their true characters.

Schwab’s hometown—Ravensburg, Germany—was the first German city to practice eugenics (killing “useless eaters”)

Ravensburg was a transport hub for stolen Nazi gold to the Swiss Bank for International Settlements run by Pilgrims Society spies Allan W. Dulles (later C.I.A. director, 1953-61), Edwin W. Pauley (Allied reparations) and William J. Donovan, director of the OSS (MI6-controlled precursor to the C.I.A.—Dulles’ boss)

Schwab’s family company, Escher Wyss, exploited slave labor and Allied POWs, manufactured key nuclear bomb-making technologies for Adolf Hitler and South Africa, sold Swiss flame throwers to the Nazis, and was named a National Socialist Model Company by Adolf Hitler

Schwab’s Escher Wyss company was protected not only by Hitler, but by Switzerland, Britain and America—making Schwab a criminal foreign meddler in every sense

.

KLAUS’ HIDDEN NAZI PAST

Klaus’ mainstream media and academia propagandists have hidden his Nazi past in a blizzard of awards, WEF programs, ghost-written books, speeches, interviews, honorary professorships and doctorates from all over the world.

AFI researchers have dubbed Klaus “old sourpuss” because he almost never smiles. Now we know why. He knows he is a fraud—a circus barker who grew up with a silver spoon in his mouth whose heart has nothing good to share with the world.

Klaus also hides that his biological mother was Jewish.

In his just-published propaganda Stakeholder Capitalism (Wiley, NY: 2021), Klaus wrote on the dedication page that his mother was Erika Epprecht. (“To my parents, Eugen Wilhelm Schwab and Erika Epprecht who taught me firsthand the value of education, collaboration, and the stakeholder principle”). This is a boldface lie.

KLAUS’S BIRTH MOTHER WAS JEWESS EMMA GISELA TEKELIUS SCHWAB (NÉE KILIAN)

Klaus and his older brother, Hans Ernst, were born to Eugen Wilhelm Schwab and Emma Gisela Tekelius Schwab (née Kilian) in Ravensburg (Mar. 30, 1938) and Karlsruhe (Oct. 13, 1927) respectively.

Hans Ernst did not disown their Jewish mother Emma like his brother Klaus has. On Dec. 09, 1938, Emma Schwab emigrated to the United States as Gisela Schwab, leaving her suckling infant Klaus, presumably forever. Was she fleeing Hitler’s Jewish persecution? Possibly. Was Klaus’ 50% Jewish blood being buried and replaced by a pure Aryan persona? Probably, especially considering his and his father’s life-long silence about her.

By contrast, wife Erika was of sturdy Aryan stock—acceptable to the Nazis. She was from Zurich, born Dec. 31, 1906, and like Vladimir Lenin, Erika lived just a ten-minute taxi ride from the Escher-Wyss turbine manufacturing campus in Zurich, according to the 1935 city directory.

Klaus’ pretend-mother Erika worked in personnel recruiting in Zurich. Ravensburg registry officials were unhelpful with birth, marriage and divorce records for Eugen Wilhelm Schwab, so no records of a divorce from Emma or re-marriage to Erika were discovered.

However, we do see Eugen and Erika traveling to Brazil in 1960, presumably to visit Hans Ernst and Escher-Wyss that Hans managed. Escher-Wyss, now Sulzer AG and Andritz AG, as well as Hilde’s Festo AG, all have large footprints in Brazilian industry, then and today.

Since Klaus hides his Jewish mother Emma—never speaking of her—we can only surmise that he suffers deep-seated abandonment issues, even now. This begs the question how this life-long maternal abandonment has affected his moral and spiritual priorities. Evidently badly.

EUGEN W. SCHWAB WAS A NUCLEAR-HAWKING RAVENSBURG CITY FATHER

Klaus’ father, Eugen Wilhelm Schwab, was the managing director of Escher-Wyss & Co. in 1938 when Klaus was born in Ravensburg, Germany, and continued with the company as President Emeritus until his death in 1982.

Escher-Wyss was founded in 1805, and developed unique engineering, manufacturing and high-strength materials capabilities focused on gas turbines, compressors, power generation, heat pumps, hydraulics, ships, thermal and hydroelectric power, and related automation controls.

Klaus has hidden Escher-Wyss Nazi sins his entire career. They are only now emerging. A few other researchers seem to have unearthed this evidence just recently as well. Much of it has been suppressed behind Top Secret archives in Switzerland, Germany, Britain and the United States—only recently released after 90+ years of in-human, diabolical suppression.

First, at the time of Klaus’ birth in 1938, Escher-Wyss had already been helping the German government build compressors, turbines and other critical elements for an emerging nuclear industry (since 1929). So, it stands to reason that as Hitler came to power, he coddled Escher-Wyss and the Schwabs.

The British 1965 propaganda film The Heroes of Telemark is about the Nazi heavy water manufacturing plant in Norway. That plant was built by Escher-Wyss.

Second, as Klaus grew into the Escher-Wyss Schwab family business, he watched his father Eugen make top secret deals with South Africa to supply key components for a nuclear bomb.

Then, when Klaus graduated from university in Zurich, funded by Escher-Wyss, he was immediately assigned to handle a 10,000-employee merger between Escher-Wyss and Sulzer AG. The merged company continued to supply nuclear bomb capabilities to South Africa with Klaus leading the effort, right up to 1971 when he started the European Management, and very probably afterwards.

FINALLY, THE BILL CLINTON PARDON OF MARC RICH ON JAN. 20, 2001 & HILLARY’S URANIUM ONE (2009) COME INTO FOCUS: RICH WAS BUSTING NUCLEAR SANCTIONS FOR KLAUS SCHWAB’S WORLD ECONOMIC FORUM CRONIES

South Africa was busting U.S. nuclear armament sanctions (clearly a ruse to fool the world public) for Sulzer-Escher-Wyss using Marc Rich, the notorious Swiss fugitive who was famously pardoned by Bill Clinton on Jan. 20, 2001. This fact alone places Klaus Schwab on the list of aiding and abetting convicted criminals like Marc Rich.

C.I.A. archive documents show that Escher-Wyss and Sulzer were being directed by the U.S. Department of Energy and the State Department. This would logically mean that Klaus Schwab was a triple-agent, working simultaneously for: (1) the CIA-MI6-UN British-Americans Pilgrims Society, (2) Nazis (now Germany) and (3) Switzerland.

Do we really want a triple-agent lying spy running the “Great Reset” and “Build Back Better?”

Third, Escher-Wyss was one of the largest employers in Ravensburg, Germany.

Fourth, Escher-Wyss was the first city in Nazi German to practice eugenics principles to murder “useless eaters” emerging from the Kaiser Wilhelm Institute (something like the National Institute of Health in the US, or Tavistock Institute in the UK).

Fifth, contrary to the propaganda stories about Ravensburg’s lack of war-making industries (as the reason why the Allies did not bomb the city and its Escher-Wyss industry), we discovered many Ravensburg unconfessed sins surrounding the Schwab’s and Escher-Wyss.

Besides parts for ships, airplanes, submarines and power plants, Escher-Wyss brokered flame throwers built in their Zurich plant and sold to the Nazis. This information comes from the U.S. Archives. This would have been handled by Eugen Schwab with a then about 5-year old Klaus at his side. They also supplied turbines, compressors and propellers for Nazi ships and submarines, as well as gas turbines for powering the war machine, in addition to their nuclear technology.

Escher-Wyss exploited slave labor (Jewish, Russian, Gypsy, homosexual, Hungarian, Romanian, Polish ), as well as Allied POWs. Being a National Socialists Model Company, this would certainly have included Dr. Josef Mengele’s biological war crimes (“The Angel of Death”).

KLAUS & HILDE’S INTERLOCKING COMPANIES EMPLOY OVER 50,000 TODAY—ALL FED BY WEF INSIDER TRADING

Escher Wyss today operates under numerous re branded names including Andritz AG and Sulzer AG. These companies are poised to profit enormously from the priorities reflected in Klaus Schwab’s so-called “Great Reset,” including hydropower, plasma turbines, nuclear power, materials science, nuclear weapons, oil and gas, coal, bio fuel, paper, food, robotics, artificial intelligence, financing, patents, pharmaceuticals and more.

Historically, the first (IBM) punch card machine readers, sometimes called Hollerith machines, were first manufactured by companies like Escher-Wyss and Sulzer who specialized in textile machines in the 1880s. Punched cards were used to created different patters on textile machines, as well as in player pianos. Other names in this business were Semyon Korsakov (ca. 1805); Charles Babbage (ca. 1855); Herman Hollerith (ca. 1880); The Tabulating Machine Company (ca. 1910), including Dehomag (Deutsche Hollerith-Maschinen GmbH, IBM Germany);  and Computing-Tabulating-Recording Company (1911, renamed IBM).

Note: IBM International president Jacques G. Maisongroung was a feature speaker at Klaus M. Schwab’s first European Management Forum on Feb. 04-07, 1971, along with the black monarch and Fourth Reich heir apparent Otto von Habsburg.

Klaus’s married Hilde Stoll in the weeks following the first Forum in 1971. This was an evident corporate marriage. Hilde’s family, to this day, owns an engineering, robotics, artificial intelligence and process controls manufacturer name FESTO with over 20,000 employees.

It should be noted that the Escher and Sulzer families are interlocked with the Stolls, Schwabs and Bodmar families. The Bodmar family property in Cologny, Geneva Canton, Switzerland is the current site of The World Economic Forum headquarters as well as the Schwab residence—like a ritzy WACO-like compound.

The Bodmar family is a 15th-century silk manufacturing family who purchased the WEF land from Fanny Moser-Sulzer (Sulzer AG). Hans von Schulthess-Bodmar was a director of Escher-Wyss & Co. and those interlocked engineering firms and exclusive private banks are still in operation today (Escher & Rahn renamed Rahn Bodmer).

Indeed, none of these family businesses have lack funding. Given their close proximity to untold amounts of stolen Nazi-Japanese gold at the Bank for International Settlements, their “success” comes into focus. In fact, it was during the Marshall Plan that the British Pilgrims Society took control of these Second-Reich family corporate empires to serve their secular new world order scheme.

Martin Bodmar was born the same year as Klaus’ father Eugen (1899). Martin was a vice-president of the International Red Cross (1940-71). Klaus is believed to have attended grade school in the Au suburb of Zurich (1945-47, ages 7-9) and lived in Bodmar castle during that posh primary schooling.

INTERNATIONAL CHAMBER OF COMMERCE CREATED A GOLD-LAUNDERING BEACHHEAD IN RAVENSBURG & FUNDED ESCHER-WYSS, SULZER, STOLL AND FESTO PERPETUALLY

Klaus had all of his schooling bankrolled by Escher-Wyss financiers in Zurich just as his father Eugen Schwab, as managing director of Escher-Wyss & Cie. (Co.) in Ravensburg was forming the Ravensburg Chamber of Commerce and Industry as vice-president (1945-46).

Eugen formed the Ravensburg Chamber of Commerce at the behest of Sir Winthrop W. Aldrich (Rockefeller, Henry Kissinger’s and Paul Volcker’s boss), Allan W. Dulles (OSS/CIA Bern, Switzerland), and the Bank for International Settlements set up by MI6 and the CIA.

The British Pilgrims Society had already begun to funnel dirty Marshall Plan funds to insider companies like Escher-Wyss and Festo and their interlocked private Swiss banking family companies, even before the war ended, in exchange for Ravensburg’s help in transporting the Nazi gold to Bill J. Donovan, Allan W. Dulles and Edwin Pauley (OSS cum MI6—the rogue C.I.A.), the British Pilgrims Society required Schwab fealty to the new world order being fronted by their newly-forming United Nations.

NoteLord Mark Malloch-Brown, the current Pilgrims Society chairman of SGO Smartmatic (with its masked OpTech ballot scanning software running in Dominion, ES&S, Hart InterCivic, Sequoia, Diebold, Premier), has served in almost every senior post at the United Nations: United Nations High Commissioner for Refugees (UNHCR) in Thailand, Africa, Central America and Geneva; Reform of UN communications; UN Development Program (UNDP); London International Model UN; UN Millennium Summit; and Deputy Secretary-General.

Note alsoSir Nigel Graham Knowles is Malloch-Brown’s fellow Pilgrim in SGO Smartmatic where he is director, chief trustee of Prince’s Trust America, and employed Kamala Harris newly-minted husband Doug Emhoff at DLA Piper LLP law.

Starting even before the Germans surrendered on May 07, 1945—just two weeks after the famous “Link-Up” (Apr. 25, 1945) of the American 69th Infantry Division with the Soviet 58th Guards in Torgau—Ravensburg was a staging ground for shipping stolen Nazi gold to Switzerland.  It has also been a processing hub for Allied POWs as evident cover for Ravensburg duplicities discussed herein.

The looted Nazi gold was routed through Ravensburg, near the Swiss-Lichtenstein border, and sent to the Bank for International Settlements in Basel, Bern and Zurich. Allen W. Dulles was the OSS spy director in Bern in charge of the Nazi gold for the Allies (Read: Pilgrims Society).

After the war, Dulles became the first director of the C.I.A. and was the man who later covered up the Kennedy Assassination in the Warren Commission, after, many believe, he ordered President Kennedy’s assassination to protect his emerging Pilgrims Society global enterprise founded on the stolen Nazi and Japanese gold—the banking system that operates today, still named the Bank for International Settlements, Zurich that handles inter banking special drawing rights.

President Kennedy was assassinated not long after he told a colleague:  “I will splinter the CIA [Dulles’ creature] into a thousand pieces and scatter it into the winds.” (New York Times, Apr. 25, 1966).

Escher-Wyss hosted numerous Sir Winthrop’s Chamber meetings in Zurich and Ravensburg sponsored by their father-son city fathers team of Eugen and Klaus Schwab.

As the Escher-Wyss managing director, Eugen was a man whose favor was sought in both Germany, Switzerland, and the Pilgrims Society, and who was grooming son Klaus to take over their Escher-Wyss dynasty, now 216 years old.

ELECTION RIGGING LEADERSHIP EMERGES FROM WEF & THEIR PILGRIMS SOCIETY OVERLORDS

Today, Klaus Schwab’s Andritz AG auditor is KPMG who also audits SERCO (controlled by the British Crown) and SGO Smartmatic (aka Dominion etc.) Voting Systems (controlled by Lord Mark Malloch-Brown and Sir Nigel Knowles, Kamala Harris’ British handler.

Klaus received a bachelor and PhD in engineering from Swiss Federal Institute of Technology, ETH Zürich, Switzerland, co-founded by Alfred Escher (1855).

Klaus also received overlapping masters and PhD degrees from the Jesuit University of Fribourg, Switzerland (1962-67). These Jesuits boast numerous Pilgrims Society globalists like British Zionist Chaim Azriel Weizmann; Basil Hume, archbishop of Canterbury; and, Juan Carlos, King of Spain.

Weizmann developed acetone used in cordite explosives for the British war industry in WWI, along with fellow British Zionist Sir Alfred M. Mond, chairman of Imperial Chemical Industries (ICI) and gunpowder—a founding member of the Pilgrims Society (1902). He also founded the Weizmann Institute, funded by Lord Victor Rothschild, that coordinated biological research closely tied to the Coronavirus patent developer (U.S. Pat. No. No. 10,130,701, awarded Nov. 20, 2018)—The Pirbright Institute (UK). In fact, Pirbright tested many of biotechnology trials in Israel, according to newly-released Dr. Sydney Brenner Victor Rothschild correspondence.

In 1966-67, Klaus was shuffled off to Boston for his Harvard grooming. He received a master’s in public administration from the John F. Kennedy School of Government. There he admits collaborating with Pilgrims Society inner circle gadabouts Henry Kissinger and John K. Galbraith. Galbraith and Kissinger came to play leading rolls in the World Economic Forum strategies and tactics.

On the wings of Kissinger’s Pilgrims Society instructions, Klaus Schwab was assigned to organize the Europe Management Forum starting in 1971.

Starting in 1965, the U.S. Department of Energy began funding the development of nuclear weapons capability in apartheid South Africa (read: British-controlled).

Newly-discovered information for this most top secret program reveal that Sulzer-Escher-Wyss supplied critical components to the enrichment of triggering of a nuclear bomb, ostensibly for the South Africans. Apparently their prized elephant herds needed protecting.

NUCLEAR WARMONGERS (KLAUS SCHWAB & HIS GOLD-DIGGING INTERLOCKED FAMILIES) ARE RUNNING THE WORLD ECONOMIC FORUM

Klaus’s first job after university was managing a 10,000-employee merger of Escher-Wyss AG and Sulzer AG. Now we know that these companies and their families were interlocked and this was merely window dressing. This occurred just as Sulzer was shipping specialize compressor and turbine seals to South Africa. Later, Swiss fugitive Marc Rich ran sanctions against South Africa for this secret Pilgrims Society nuclear cabal.

“Schwab’s Sulzer, Escher Wyss companies have been one of the world’s top suppliers of nuclear turbine and enrichment technologies”

Also see: 7 LITTLE KNOWN FACTS ABOUT #THEGREATRESET MASTERMIND KLAUS SCHWAB

I made this past September, didn’t I?
Who’s a nazi now? 🙂

We are funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

We gave up on our profit shares from masks, if you want to help us, please use the donation button!
We think frequent use, even short term use can be bad for you, but if you have no way around them, at least send a message of consciousness.
Get it here!

We found a contractual clause between governments and Covid jabs manufacturers that may end the pandemic no later than this summer.

A question from Sky News, we know better because we can critically analyze their reports better than they do

We’ve just learned that AstraZeneca (and likely other vaccine manufacturers) can’t properly milk their new cash cow before the pandemic is over. Several of the biggest contracts closed so far between governments and vaccine manufacturers stipulate that profits won’t be paid before the pandemic is officially declared over.

AstraZeneca, which has promised not to profit from its Covid-19 vaccine “during the pandemic”, has the right to declare an end to the pandemic as soon as July next year, according to a document seen by the Financial Times.

An Oxford University press release confirms:
“A key element of Oxford’s partnership with AstraZeneca is the joint commitment to provide the vaccine on a not-for-profit basis for the duration of the pandemic across the world, and in perpetuity to low- and middle-income countries. “

Also, according to Sky News Australia, “AstraZeneca has committed that the vaccine will be made on a not-for-profit basis as long as COVID-19 is classified as a pandemic, and will remain so when sold to developing nations.
Should the disease recede and the vaccine become an annual defence against COVID-19 sold at a profit, Professor Gilbert, her close colleagues, the university, and a range of private and corporate investors – including Google’s parent company Alphabet – all stand to benefit.”

Note that AstraZeneca is a member of the World Economic Forum (think The Great Reset), same as Pfizer, Moderna and J&J, and Google is a shareholder, so they have amassed more support than a country can raise.

These claims are also supported by their main partners in AstraZeneca, Oxford Science Innovation, who says:
“In the interest of accelerating global vaccine development, Vaccitech assigned its rights to the vaccine candidate to Oxford University Innovation, to facilitate the licence of those rights to AstraZeneca for the development and manufacture of the vaccine. None of the parties will profit from vaccine sales during the pandemic.
Vaccitech is backed by leading investment institutions, including GV (formerly Google Ventures), Sequoia Capital China, Liontrust (formerly Neptune), Korea Investment Partners and Oxford Sciences Innovation.”

So Google is a Pharmafia giant who also controls the media and can censor any inconvenient report on its services and products

The problem is that the propaganda and the fear porn didn’t work as they hoped (nothing does when you’re as deranged as they are) and the governments are way behind the schedule with inoculations and other related affairs, hence the prolonged lockdowns in some parts of the world. If they open in summer, they will lose even more customers and they can’t use the emergency situation excuse to inject people with hazardous untested chemicals like these mRNA jabs.


This is what obliges Google and the Gang to ramp up censorship and propaganda.
So now Pharmafia insiders (lower level salesmen) inform us that the powers behind these covid jabs are pressuring governments to end the pandemic and start the payments. But that’s hardly achievable and politicians find themselves between a rock and a hard place.


We’ve said before that this state of emergency has no end in sight because it’s a necessary condition for injecting experimental garbage into the gullible masses. It was mostly true but we’ve already corrected that statement because this new revelation might just bring that end.


Some governments may be able to win a few extra-months, but it’s very likely that many will not have that power and will do whatever stunt necessary to please their Pharmafia overlords.

This is how you may explain the unexplainable recent plunge in case stats too.
As we showed before, they have a knob that can control the stats: the PCR test cycle threshold. The higher, the more positive results.
As the pandemic was scheduled to ease and the covid business to normalize after Biden/WEF’s hostile takeover of US Government, WHO ordered lowering the threshold precisely on Biden’s inauguration day and these are the immediate results. Which also proves how they pumped up the numbers before.

Financial Times goes into details:
<<While some companies said from the outset they can only develop the vaccine for profit, others, such as AstraZeneca and Johnson & Johnson, have agreed to provide doses on a cost basis for at least as long as the pandemic lasts.
The memorandum of understanding, seen by the FT, outlines the conditions of a deal signed in July between AstraZeneca and Fiocruz, a Brazilian public health institution, to produce at least 100m vaccine doses, worth more than $300m.The document states that for the purposes of the MoU and the “Definitive Agreements” the pandemic will be considered over on July 1, 2021. The so-called “Pandemic Period” could be extended but only if “AstraZeneca acting in good faith considers that the SARS-COV-2 pandemic is not over”, it says. 

Pascal Soriot, AstraZeneca’s chief executive, has previously said that a number of factors would influence the company’s assessment of when the pandemic is over, including the World Health Organisation’s own analysis, but has not been more specific. He has also declined to disclose a post-pandemic price point.
The WHO declared the current outbreak a pandemic in March. More than 1m have died and cases globally show no sign of tapering. Even optimistic forecasts predict an approved vaccine is unlikely to be widely available for public vaccination campaigns before the middle of next year.
AstraZeneca declined to answer specific questions regarding its definition of the “Pandemic Period” or the Fiocruz agreement.
“From the outset, AstraZeneca’s approach has been to treat the development of the vaccine as a response to a global public health emergency, not a commercial opportunity,” the company said in a statement. “We continue to operate in that public spirit and we will seek expert guidance, including from global organizations, as to when we can say that the pandemic is behind us.”
Oxford university also declined to respond to specific questions. “The terms of our agreement are confidential but uphold Oxford’s commitment to fair and equitable access to the vaccine for the duration of the pandemic should it prove to be effective in our global phase 3 clinical trials,” the university said.
Public health experts say many of the vaccine deals, including those involving AstraZeneca, are shrouded in secrecy, offering little room for scrutiny.

Manuel Martin, medical innovation and access policy adviser at Médecins Sans Frontières, said the terms of the Fiocruz MoU gave AstraZeneca “an unacceptable level of control over a vaccine developed through public funds”. “Relying on voluntary measures by pharmaceutical corporations to ensure access is a mistake with fatal consequences,” he said.
AstraZeneca has received large amounts of public money to develop its vaccine and secure forward orders, including at least $1bn from the US. Supply deals to date indicate that the vaccine, which requires two doses, is priced at about $3 to $4 per dose, lower than the prices disclosed or reported for other potential vaccines.
Ellen Hoen, director of Medicines Law & Policy, a non-profit campaigning for greater access to medicines, said more transparency was needed.
“Despite all the talk about the Covid-19 vaccine needing to be a ‘global public good’ by political leaders who spend billions on Covid-19 R&D, it seems that it is the drug companies that determine, in secret deals, who will get access to the vaccine and when,” she said.>>

If this trend keeps going on a bit longer, it very likely means that they are staying on the course and many countries will officially end the pandemic starting June/July.

And that will force them do more stupid stunts we can’t wait to expose.
They already are stumbling at all levels, from production and distribution to research. Last minute news from Financial Times inform that “Scientists are demanding to know why AstraZeneca’s paused trial of its Covid-19 vaccine is still on hold in the US while it has been restarted elsewhere, worrying it could damage public trust there. The trial was originally halted because a UK participant developed a serious inflammatory condition. In the US, it has been on hold for almost two weeks, while trials in other countries including the UK have restarted.
Ashish Jha, dean of the school of public health at Brown University, said: “Normally, companies wouldn’t give out information in the middle of a trial, but this is an exceptional case and we need to have radical transparency. Otherwise, there is a risk the public will lose confidence in the whole process.”
AstraZeneca is telling participants in resumed trials that the “unexplained neurological symptoms” were either unlikely to be associated with the vaccine or that there was “insufficient evidence” to say whether they were or were not associated, and so independent reviewers had recommended that vaccinations continue. Clinical trials do not usually publish data before hitting pre-determined milestones.”

LAST MINUTE UPDATE: This came in hours after we published this. Ah, well…

Source

As a side note: watch the video from the above source and everything featuring Fauci this year and tell me he didn’t have better energy and mood during Trump’s mandate. I blame that on the fact that Trump was the best pro-vaccine campaigner they had and now that he’s gone from the screens, they’re in shambles. But that’s just me.

We are funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

CLICK

With one exception, everything YouTube banned from us was good and meaningful information that’s never been debunked, or legit skepticism and inquiry. This interview should be no exception.
Besides the shocking “coincidences” with current events.

They deleted it before I even had the chance to edit the title 😀

The full text of my appeal to YouTube’s ban:

We all know you have no competence, capability, grounds or rights to do what you are claiming to do, and, in fact, you’re deleting stuff because it exposes your own business. But an YouTube ban brings me more traffic than I lose on your crappy narrative-enforcement machine, so keep up the great work! 😉

Also available on our Odysee channel

January 2014 interview with Anthony Patch, founder of Entangled Magazine an insightful and revelatory digital publication focused on current advances and pronouncements in: Quantum Computing, Artificial Intelligence, Cryptocurrencies/Blockchain, Quantum Mechanics, DNA/RNA Modification.

His YouTube channel has also been deleted, but he’s active on Bitchute.

I can’t vouch for some of the things he (or anyone) is saying on his channel, but smart people have a lot to learn from what he puts out.
Other than that, see our motto in the website header 😉

We are funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

One of the most important truths that are obfuscated by Pharmafia’s propaganda machine: not only vaccine safety is very poorly studied, but there has been done precisely 0 (zero) research on the cumulative and synergetic effect of all the shots in the various vaccine schedules enforced by governments around the world.
Meaning that we know jack-shizzle about their combined effect.
Here’s an example of how that plays out against vaccines and serial dupes.

Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010–2011 to 2014–2015 

Danuta M. SkowronskiCatharine ChambersGaston De SerresSuzana SabaiducAnne-Luise WinterJames A. DickinsonJonathan B. GubbayKevin FonsecaSteven J. DrewsHugues CharestChristine MartineauMel KrajdenMartin PetricNathalie BastienYan LiDerek J. SmithAuthor NotesThe Journal of Infectious Diseases, Volume 215, Issue 7, 1 April 2017, Pages 1059–1099, https://doi.org/10.1093/infdis/jix074

Published: 09 February 2017 Article history

Abstract

Background.

The antigenic distance hypothesis (ADH) predicts that negative interference from prior season’s influenza vaccine (v1) on the current season’s vaccine (v2) protection may occur when the antigenic distance is small between v1 and v2 (v1 ≈ v2) but large between v1 and the current epidemic (e) strain (v1 ≠ e).Methods.

Vaccine effectiveness (VE) against medically attended, laboratory-confirmed influenza A(H3N2) illness was estimated by test-negative design during 3 A(H3N2) epidemics (2010–2011, 2012–2013, 2014–2015) in Canada. Vaccine effectiveness was derived with covariate adjustment across v2 and/or v1 categories relative to no vaccine receipt among outpatients aged ≥9 years. Prior vaccination effects were interpreted within the ADH framework.Results.

Prior vaccination effects varied significantly by season, consistent with the ADH. There was no interference by v1 in 2010–2011 when v1 ≠ v2 and v1 ≠ e, with comparable VE for v2 alone or v2 + v1: 34% (95% confidence interval [CI] = −51% to 71%) versus 34% (95% CI = −5% to 58%). Negative interference by v1 was suggested in 2012–2013 with nonsignificant reduction in VE when v1 ≈ v2 and v1 ≠ e: 49% (95% CI = −47% to 83%) versus 28% (95% CI = −12% to 54%). Negative effects of prior vaccination were pronounced and statistically significant in 2014–2015 when v1 ≡ v2 and v1 ≠ e: 65% (95% CI = 25% to 83%) versus −33% (95% CI = −78% to 1%).Conclusions.

Effects of repeat influenza vaccination were consistent with the ADH and may have contributed to findings of low VE across recent A(H3N2) epidemics since 2010 in Canada.

Read the body of the research on its site if you need, we’re jumping to the final discussion, with our emphasis added. It’s stuff that goes against the new terms and conditions set up by the sellout social media / Big Tech, who are cancelling the science that’s not fitting their narrative

DISCUSSION

Using databases of the Canadian SPSN, we explored the extent to which repeat vaccination effects may have contributed to suboptimal influenza vaccine performance during recent A(H3N2) epidemics in Canada. We interpret our findings within the framework of the ADH, comparing observed effects measured by the TND with predicted patterns based on the antigenic relatedness between prior season’s vaccine (v1), current season’s vaccine (v2), and the circulating epidemic strain (e). This is the first modern attempt to directly correlate AD metrics with epidemiological observations of v1 effects and their overall fit within the ADH paradigm since it was first formulated nearly 2 decades ago.

Across the 3 A(H3N2) epidemics since 2010–2011 in Canada, no adjusted seasonal VE estimate exceeded 40%, even among mostly healthy, working-age adults. Each of these epidemics was associated with a vaccine-mismatched strain (v2e), although variation in VE was not obviously correlated with the AD (or match) between v2 and e. Adjusted VE was highest in 2010–2011 (40%; 95% CI = 9% to 60%), similar in 2012–2013 (31%; 95% CI = −4% to 55%), but dramatically lower in 2014–2015 (−12%; 95% CI = −47% to 15%) despite comparable v2–e ADs ranging 4–6. In the original report of the ADH, Smith et al also highlighted a lack of correlation between VE and the v2e distance in first-time vaccines [15]. Because A(H3N2) epidemics are associated with the greatest influenza disease burden [21], understanding the agent–host factors that contribute to low VE is critical. Our findings suggest that prior vaccination may modify current VE and that this effect may vary by season according to the ADH. Given heterogeneity in the conditions of vaccine–virus relatedness, we should expect v1 effects on current season’s VE to vary by season. Pooling or averaging across seasons may enhance statistical power but at the risk of masking meaningful variation and insights to inform mechanisms and implications; further explorations of prior influenza vaccination effects should stratify results by season and subtype.

During the 3 A(H3N2) epidemics presented here, observed v1 effects included no modification, as well as significant negative interference; we did not observe positive interference (ie, enhanced protection), also possible within the ADH framework but under specific conditions not found during epidemics included here [15]. In 2010–2011, when v1 and v2 were antigenically distinct (v1 ≠ v2), minimal or no interaction was expected or observed. Conversely, with closer but nonhomologous v1 and v2 relatedness in 2012–2013 (v1 ≈ v2), the expected pattern of negative interference was apparent, although, with limited sample size, effect modification was not statistically significant. As anticipated based on the ADH, the negative effects of prior vaccination on the current season’s VE were most pronounced and statistically significant in 2014–2015 with homologous v1 and v2 antigens (v1 ≡ v2) and antigenically distinct circulating epidemic virus relative to v1 (v1 ≠ e).

Although antigenic drift has been widely emphasized to explain the historically low VE in 2014–2015, the AD between v2 and e was not estimated to be dramatically different from recent prior seasons [101122–24]. Conversely, prior vaccination had marked effects, negating the otherwise moderate VE observed among v2-only recipients despite vaccine mismatch. A similar pattern of moderate VE among v2-only recipients, substantially reduced with receipt of the prior season’s homologous vaccine, was also reported for 2014–2015 in multicountry analysis from Europe [11] but not from the United States, where VE against A(H3N2) was negligible in all categories of current and prior vaccine recipients [23]. In the Canadian data, a dramatic increase in the distribution of influenza A(H3N2) cases reporting prior vaccination was observed in 2014–2015 whereas controls showed the expected trajectory of gradual increase, reflecting vaccine coverage trends in the general source population [2526]. In all seasons, vaccination status was based on patient self-report and practitioner documentation before either knew the patient’s case versus control status (ie, influenza test positivity result), minimizing differential recall bias and heightening the plausibility of the observation particular to cases in 2014–2015.

In 2014–2015 in Canada, under the specific conditions of v0 ≈ v1 ≡ v2 ≠ e, serial vaccination was associated with a nearly 50% increased risk of medically attended A(H3N2) illness relative to participants who were consistently unvaccinated. Statistically significant increased risk (OR = 1.85; 95% CI = 1.17–2.90) of A(H3N2) illness in 2014–2015 was also reported from Italy, where vaccinated participants were also mostly repeat recipients [24]. The 2014–2015 epidemic is the first season in more than a decade of annual VE monitoring for which the Canadian SPSN reported vaccine-associated increased risk, and caution is warranted in its interpretation. However, increased risk was previously reported by multiple studies from Canada and elsewhere during the 2009 A(H1N1)pdm09 pandemic in association with prior receipt of mismatched 2008–2009 seasonal vaccine, replicated also in at least 1 randomized controlled study in ferrets [27–31]. Influenza vaccine-associated enhanced respiratory disease (VAERD) is a well-recognized phenomenon following heterologous challenge in vaccinated swine, most of whom recover [32]. Although animal experiments may not be directly relevant to human experience, elements of involved mechanistic pathways may overlap and inform biological plausibility.

The ADH is a useful conceptualization but is not amenable to exact extrapolation [15]. The originally published simulations were based on AD between v2 and e set at 2 with variability explored around v1v2 and v1e. Sensitivity analyses explored effects of homologous vaccination ranging up to a v2e distance of 3, but not greater. Emphasis was placed on the prior season’s vaccination; the effects of earlier or multiple prior virus or vaccine exposures were not considered. The ADH predicts relative, but not absolute, VE, and the possibility that serial vaccine receipt might be associated with increased risk under some conditions was not considered, although such signals may have already been evident in the studies by both Hoskins and Keitel under specific conditions of multiple repeat vaccinations and v1v2, and e relatedness [34] (Supplementary Figures 1 and 2). The ADH is predicated on the HI assay, but variability in HI results by assay conditions must be acknowledged [1620]. For example, in 2 of 3 epidemics analyzed here (2010–2011, 2012–2013), Canada’s national influenza reference laboratory characterized all viruses as well-matched to the WHO-recommended v2 reference strain (AD < 3) [893334]. Those characterizations, however, were in relation to the cell-passaged v2 referent (whereas manufacturers use an egg-adapted reassortant), included varying animal-source erythrocytes, and did not include oseltamivir to address neuraminidase (NA)-mediated effects [89]. We based our AD calculations on HI assays standardized for these conditions by the WHO Collaborating Centre for Reference and Research on Influenza (London) [19]. Even so, further variability in the mix of variants by setting, the representativeness of selected reference strains, and changes induced by laboratory passaging complicates AD derivation, interpretation, and generalization. Future evaluations and their extrapolation would benefit from the assembly of a standard and definitive library of HI characterizations and ADs between specific egg-passaged vaccine strains and circulating genetic variants each season. The incorporation of modern genomic, bioinformatic mapping and antibody landscape approaches could also improve resolution in the understanding of vaccine-virus relatedness and response [3536].

Vaccine effects beyond those involving the HA1 (ie, HA2 or NA) and other agent-host immunological influences beyond (or complementary to) the ADH likely also play a role, including possible heterosubtypic effects of trivalent vaccine not otherwise considered. Original priming (eg, imprinting) and prominent recall (eg, back-boosting) responses to historic influenza exposures can shape hierarchical antibody responses, with either positive or negative implications [37–42]. Annually repeated vaccination, compared with less frequent infection exposures, may accelerate antibody refocusing toward prior versus evolved epitopes, with selection for cross-reactive but non-neutralizing memory responses [43]. In the context of preexisting antibody, immune complex formation and Fc-receptor activation can suppress B-cell response to subsequent influenza vaccine doses [44]. Antibody-dependent mechanisms may also suppress innate cytokine signaling pathways required for proinflammatory T-cell responses [45], and in children, annual repeat vaccination has been reported to hamper development of virus-specific CD8+ T-cell immunity [46]. Repeat vaccination may also select for T-cell responses that are antagonistic, such as preferential activation and/or recruitment of regulatory cells upon reexposure [47]. Such mechanisms may also modify risk in previous but not current vaccine recipients. Ultimately, the mechanisms to explain the potential negative effects of repeat vaccination remain unknown but are likely multifactorial, requiring a more complex systems approach to resolve [48].

Random and systematic error, including residual confounding and behavioral differences, may also contribute to findings. Few A(H3N2) epidemics were analyzed here, and each season represented a unique set of specific vaccine–virus relatedness conditions. Sample size in our indicator-variable analyses was also limited. Additional seasons are required before definitive conclusions can be drawn about correlation with the ADH. Population-based immunization registries are not available in Canada for the study period, but self-report is considered an accurate predictor of influenza vaccination status, as demonstrated in US analyses relative to registry data for both current [49] and prior season’s vaccination status (Ed Belongia Marshfield Clinic Research Foundation, personal communication), especially among adults who comprise the majority (86%) of our participants. We have the greatest confidence in VE estimates for repeatedly vaccinated relative to consistently unvaccinated participants, both in terms of reliable personal recall of vaccine history and also statistical certainty owing to sample size, but less confidence in smaller subsets of participants reporting more erratic vaccination behaviors. Change in vaccination habit may be correlated with influenza risk, a bias that has been raised previously in deriving VE estimates in elderly adults based on administrative datasets but also potentially relevant in assessing current/prior vaccination effects using an observational design [50]. First-time vaccinees may have been newly motivated to receive influenza vaccine because of recent acute respiratory illness, possibly due to influenza. In the context of recent prior infection, vaccine responses may be enhanced [51] and/or VE may be overestimated through confounding by more durable and cross-protective infection-induced immunity. We did not have data available on prior infection history, but the proportion of newly vaccinated individuals with that recent history would have to be substantial to meaningfully influence VE estimates. Prior vaccination may have conversely blocked opportunity to acquire infection-induced immunity (ie, infection-block hypothesis), leading to underestimation of VE in the recurrently vaccinated—an indirect mechanism for repeat vaccination effects originally favored by Hoskins but insufficient to fully explain observed effects of vaccine-associated increased risk [32731].

In summary, serial vaccination may have contributed to poor influenza vaccine performance during recent A(H3N2) epidemics in Canada. The ADH remains a useful framework for reconciling variability in repeat vaccination effects but requires update to incorporate recent epidemiological findings, modern and standardized laboratory approaches for monitoring vaccine–virus relatedness and response, and a broader understanding of immunological context and consequences. Integrated immuno-epidemiological evaluation across an extended horizon is needed to understand the spectrum of repeat vaccination effects and to determine whether annual influenza vaccination is likely to provide long-term advantage at the individual or population levels—a return to the question first posed by Hoskins 40 years ago [3].

We are funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Sometimes my memes are 3D. And you can own them. Or send them to someone.
You can even eat some of them.
CLICK HERE

War is peace and truth is fake news in Covidiocray.
I hear there’s many more “fact-checks” on this, published by other presstitutes, that all seem copied from the same press-release or something…

First off: a New Scientist short article, as old as 2008, in verbatim copy, to take the bacteria debate out of the way

Bacteria were the real killers in 1918 flu pandemic

HEALTH 4 August 2008

By Ewen Callaway

New Scientist Default Image
(Image: US National Museum of Health and Medicine)

Medical and scientific experts now agree that bacteria, not influenza viruses, were the greatest cause of death during the 1918 flu pandemic.

Government efforts to gird for the next influenza pandemic – bird flu or otherwise – ought to take notice and stock up on antibiotics, says John Brundage, a medical microbiologist at the Armed Forces Health Surveillance Center in Silver Spring, Maryland.

Brundage’s team culled first-hand accounts, medical records and infection patterns from 1918 and 1919. Although a nasty strain of flu virus swept around the world, bacterial pneumonia that came on the heels of mostly mild cases of flu killed the majority of the 20 to 100 million victims of the so-called Spanish flu, they conclude.

“We agree completely that bacterial pneumonia played a major role in the mortality of the 1918 pandemic,” says Anthony Fauci, director of National Institute for Allergy and Infectious Disease in Bethesda, Maryland, and author of another journal article out next month that comes to a similar conclusion.

Double whammy

That pneumonia causes most deaths in an influenza outbreak is well known. Late 19th century physicians recognised pneumonia as the cause of death of most flu victims. While doctors limited fatalities in other 20th-century outbreaks with antibiotics such as penicillin, which was discovered in 1928, but did not see use in patients until 1942.

This is not to say that flu viruses do nothing, says Jonathan McCullers, an expert on influenza-bacteria co-infections at St Jude Children’s Research Hospital in Memphis, Tennessee.

McCullers’ research suggests that influenza kills cells in the respiratory tract, providing food and a home for invading bacteria. On top of this, an overstressed immune system makes it easier for the bacteria to get a foothold.

However, the sheer carnage of 1918 caused many microbiologists to reconsider the role of bacteria, and some pointed their fingers firmly at the virus.

‘Unique event’

When US government scientists resurrected the 1918 strain in 2005, the virus demolished cells grown in a Petri dish and felled mice by the dozen.

“The 1918 pandemic is considered to be – and clearly is – something unique, and it’s widely understood to be the most lethal natural event that has occurred in recent human history,” Brundage says.

But to reassess this conclusion, he and co-author Dennis Shanks, of the Australian Army Malaria Institute in Enoggera, Queensland, scoured literature and medical records from 1918 and 1919.

The more they investigated, the more bacteria emerged as the true killers, an idea now supported by most influenza experts.

For instance, had a super virus been responsible for most deaths, one might expect people to die fairly rapidly, or at least for most cases to follow a similar progression. However, Shanks and Brundage found that few people died within three days of showing symptoms, while most people lasted more than a week, some survived two – all hallmarks of pneumonia.

Local bugs

Military health records for barracks and battleships also painted a different picture. New recruits – men unlikely to have been exposed to resident bacteria – died in droves, while soldiers whose immune systems were accustomed to the local bugs survived.

And most compelling, Brundage says, medical experts of the day identified pneumonia as the cause of most deaths.

“The bottom line is we think the influenza virus itself was necessary – but not sufficient – to cause most of the deaths,” he says.

As the world’s health experts prepare for the next influenza pandemic, many have looked to 1918 as a guide, planning for a deadly super-virus.

The H5N1 bird flu strains jetting around the world seem to kill humans without the aid of bacteria, but those viruses aren’t fully adapted to humans, McCullers says. If H5N1 does adapt to humans, bacteria may play a larger role in deaths, he adds.

“Everyone is focused exclusively on the virus, and that’s probably not the best idea,” he says.

Antibiotics and vaccines against bacterial pneumonia could limit deaths in the next pandemic. And while an effective influenza vaccine should nip an outbreak in the bud, such a vaccine could take months to prepare and distribute.

“The idea of stockpiling [bacterial] vaccines and antibiotics is under serious consideration,” says Fauci, who is on a US government taskforce to prepare for the next flu pandemic.

At a recent summit on pandemic influenza, McCullers said health authorities were increasingly interested in the role bacteria might play, but there had been little action taken.

“There’s no preparation yet. They are just starting to get to the recognition stage,” he says. “There’s this collective amnesia about 1918.”

Journal reference: Emerging Infectious Disease (DOI: 10.3201/eid1408.071313)

and this is the fun part where reuters confirms everything in a desperate and hilarious debunk attempt

Ladies and gents, Facebook’s premium smear-machine aka “fact-checkers”, aka establishment’s mouth-pieces licensed to kill competition, aka world’s #1 news agency are back in the spotlight after another comical attempt against one of our reports.
The scenario is similar: they make up straw-men and give them a naive beatdown with a lot of laughable BS show off. But this one is a legendary performance that needs to become a classic reference.

I peed my pants a little from the first paragraph:

What this means is that for a week, these useless nitwits ran the debunk without even getting the incriminated study right.
Like how do they even breathe… ah, wait, they’re maskers…

After a bunch of fill in because they’re paid by word, they land their only point and argument:

To claim the 1918-1919 flu pandemic deaths were caused by bacterial pneumonia alone is inaccurate.

Reuters

I bolded “alone” because that’s how they attempt to “virus” the discussion.

No one said “alone” before them and no one made the claim they are arguing.
So no, they debunked a claim they themselves made up. Or did they?
More so, in exactly the paragraph that precedes their argument, they 200% CONFIRMED the claim that went viral:

See anyone saying “alone”?

Fauci makes it very clear in his description of the study that bacterial pneumonia was preceded by the influenza virus: “The weight of evidence we examined from both historical and modern analyses of the 1918 influenza pandemic favors a scenario in which viral damage followed by bacterial pneumonia led to the vast majority of deaths. In essence, the virus landed the first blow while bacteria delivered the knockout punch.” (here).

Reuters

That part bolded in Fauci’s quote is our claim, it proves the official narrative was BS for over a century and now we have Reuters to vouch for it. Thank you, Reuters, we couldn’t advance The Great Awakening so fast if you NPCs weren’t polar opposites to genius! 😉

And guess what, they can’t even beat their own strawman, because the flu may have started something in 1918, but bacteria ALONE delivered the knockout punch. And there would be no knockouts is it wasn’t for knockout punches, ya kno…

So, maybe to claim the 1918-1919 flu pandemic deaths were caused by bacterial pneumonia alone is NOT that inaccurate. If someone breaks your legs and someone else takes advantage later to kill you, only the latter goes to jail for homicide. And, to be honest, I could use more evidence on the lethal contribution of that first viral blow.

Children can debunk a Reuters debunk

As for the mask connection, science has not definitively demonstrated the direct causal relationship between masks and the 1918 bacterial pneumonia pandemic, but, based on the knowledge available so far, masks are generally associated with higher bacterial risk, from candida to “maskne”. So don’t tell people to look elsewhere, if you find a better culprit, first write a paper and get the Nobel you deserve. Until then, we have all the reasons to point at masks as a very likely suspect and demand much more caution. No one has even attempted that paper in quite a while because no one’s been that dumb, but we can always hope that from Reuters.

… BUT IF YOU’RE HERE MOST LIKELY YOU’RE NOT 😉

By the way, call that “anecdotal” or whatever, but my home country, Romania, has been officially birthed through a series of very large mass gatherings with no masks and no distancing, precisely during the 1918 pandemic. And I have all the reasons to think that lack of masks is what kept them safe, the pandemic being hardly noticed locally, at the time.

We are funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Our nano-grand-jury has settled: best scamdemic videos of 2021 so far, and for a while, are:

YOUTUBE BANNED OUR VIDEO IN LIKE 30 MIN, BUT WE ALREADY HAVE IT ON ODYSEE / BITCHUTE / BRIGHTEON

Seems like Youtube hurried to prove our point lmao

UPDATE: WE’RE FIRING BACK AT YOUTUBE CENSORSHIP WITH THEIR WEAPONS, OUR STRATEGY AND BACK-UP CHANNEL. FOR THIS TO WORK, WE VERY MUCH NEED TO SEE SOME LOVE FOR THIS ARTICLE AND THE VIDEO BELOW, WHICH HAS TO BECOME POPULAR ON YOUTUBE, NOT ELSEWHERE, WE NEED TO SCORE ON THEIR FIELD IF WE ARE TO WIN THE CHAMPIONSHIP! THANK YOU!

THE PART 2 OF OUR EULOGY SURVIVED THE YOUTUBE SCIENCE SLAUGHTER

Amen

We are funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Anyone who has any remnants of humanity inside has asked this question.
One answer is no secret to anyone: poor countries. But that’s not always the case, and this is where it gets darker.

The ethics of deliberately infecting volunteers with Covid-19 to test vaccines are a complicated issue only if you value something more than human life, which is actually common, but not the case here. So I’m not making a secret that everything I know and feel made me conclude long ago that most medical tests that occurred on humans were abominations permitted only by a massive lack of empathy / humanity and usually driven by financial incentives. Everything that followed after that was but a confirmation. Point being: I’m long over that debate, there is absolutely no essential difference between the Bayer labs in Auschwitz and the Pfizer Labs in London (or wherever).
And I know a large slice of society, if not the majority, still has major moral, rational and ethical concerns about this, luckily, and it can’t be that easy to find these kids without leveraging finances on poorest people, and even then…
Proof to that, Moderna has just publicly admitted it has big difficulties in finding 3000 kids, and I hope they never sort it out. So much so that They appealed to all their presstitutes to make a roll call for them.
Funnily, only days after Moderna’s appeal, CBS lies that they were having “more than enough volunteers, so basically these two messages are now still being propagated simultaneously:
“Last fall, the Clinical Research Institute sent out letters to pediatricians’ offices and posted on Facebook looking for volunteers in the 12-year-old to 17-year-old age group. Though the study will run for 13 months, the researchers have more than enough volunteers for this trial.” – CBS


Since you can’t expect anyone involved to be honest and open about it, based on their past and present performance, and they’re not, where to find the answer? There’s about 50 vaccines being trialed right now, some are moving into babies as young as 6 months old, this IS urgent!
If you need another reminder why, go to Forbes and read “The Hideous Truths of Testing Vaccines on Humans”, or watch the videos below.

To get back to the headline question, remember wherever demand forms, a market forms and an industry develops.

A 2017 report in Gizmodo, entitled “How a Company You’ve Never Heard of Sends you Letters about your Medical Condition,” quotes a company called Acurian saying it purchases “public information” and “lifestyle data” to find candidates.

It does not access your doctor’s medical file. Here are some excerpts:

In the summer of 2015, Alexandra Franco got a letter in the mail from a company she had never heard of called AcurianHealth. The letter, addressed to Franco personally, invited her to participate in a study of people with psoriasis, a condition that causes dry, itchy patches on the skin.

Franco did not have psoriasis. But the year before, she remembered, she had searched for information about it online, when a friend was dealing with the condition. And a few months prior to getting the letter, she had also turned to the internet with a question about a skin fungus. It was the sort of browsing anyone might do, on the assumption it was private and anonymous.

Now there was a letter, with her name and home address on it, targeting her as a potential skin-disease patient. Acurian is in the business of recruiting people to take part in clinical trials for drug companies. How had it identified her? She had done nothing that would publicly associate her with having a skin condition.

When she Googled the company, she found lots of people who shared her bewilderment, complaining that they had been contacted by Acurian about their various medical conditions. Particularly troubling was a parent who said her young son had received a letter from Acurian accurately identifying his medical condition and soliciting him for a drug trial—the first piece of mail he’d had addressed to him besides birthday cards from family members.

Acurian has attributed its uncanny insights to powerful guesswork, based on sophisticated analysis of public information and “lifestyle data” purchased from data brokers. What may appear intrusive, by the company’s account, is merely testimony to the power of patterns revealed by big data.

“We are now at a point where, based on your credit-card history, and whether you drive an American automobile and several other lifestyle factors, we can get a very, very close bead on whether or not you have the disease state we’re looking at,” Acurian’s senior vice president of operations told the Wall Street Journal in 2013.

Yet there’s some medical information that Acurian doesn’t have to guess about: The company pays Walgreens, which uses a privacy exemption for research, to send recruitment letters to its pharmacy customers on Acurian’s behalf, based on the medications they’re using. Under this arrangement, Acurian notes that it doesn’t access the medical information directly; the customers’ identities remain private until they respond to the invitations.

And that is not the entire story. An investigation by the Special Projects Desk has found that Acurian may also be pursuing people’s medical information more directly, using the services of a startup that advertises its ability to unmask anonymous website visitors. This could allow it harvest the identities of people seeking information about particular conditions online, before they’ve consented to anything.

A letter sent out to a Walgreens customer in Connecticut on Acurian’s behalf. It invited her to visit a generic sounding website for people with pulmonary disease. At the time, she had a prescription from Walgreens for asthma.
A letter sent out to a Walgreens customer in Connecticut on Acurian’s behalf. It invited her to visit a generic sounding website for people with pulmonary disease. At the time, she had a prescription from Walgreens for asthma.

If you’re suddenly thinking back on all of the things you’ve browsed for online in your life and feeling horrified, you’re not alone.

AcurianHealth has created dozens and dozens of generic sounding websites for the trials they’re recruiting for: www.trialforCOPD.com, www.studiesforyourarthritis.com, and www.kidsdepressionstudy.com are a few examples of the many websites they own. The sites all feature stock images of people in distress, sometimes include AcurianHealth’s logo, and include promises of up to $1,000 for participating, depending on the study.

An example of one of the Acurian sites, www.sleepapneastudies.com
An example of one of the Acurian sites, http://www.sleepapneastudies.com

Out of view, some of these sites include something else: code from a company called NaviStone—which bills itself as a specialist in matching “anonymous website visitors to postal names and addresses.” So if a person is curious about one of those letters from Walgreens, or follows one of Acurian’s online ads, and visits one of Acurian’s generic disease-specific sites, their identity could be discovered and associated with the relevant condition.

NaviStone says it can send personalized mail to anonymous website visitors with a day or two of their visit.
NaviStone says it can send personalized mail to anonymous website visitors with a day or two of their visit.

This tracking function undermines what’s supposedly a formal separation between Walgreens customer data and Acurian’s recruitment. If Walgreens sends out a bunch of letters to customers taking certain medications, and those customers then visit the generic website controlled by Acurian provided in the letter, Acurian can infer its wave of new visitors are taking those medications—and, if NaviStone delivers on its promise to identify visitors, Acurian can see who they are.

Walgreens gives itself permission to use customers’ health information for “research” purposes, which would include clinical trials, in its privacy policy. It’s been working with Acurian since at least 2013, and in 2015, Walgreens announced it was “leveraging” its 100 million customer database to recruit patients directly for five major drug companies.

When asked about its partnership with Acurian, Walgreens spokesperson Scott Goldberg pointed me to a Walgreens FAQ page about clinical trials. It states that Walgreens doesn’t share health information with third parties without permission, but that a third party may “receive your information if you contact the web-site and/or toll-free number in the letter to seek more information about the clinical trial.”

The question is whether users will know that one of Acurian’s websites has received their information—even if they haven’t necessarily agreed to submit it. NaviStone, an Ohio-based business spun out from the marketing firm CohereOne last year, claims to be able to identify between 60 and 70 percent of anonymous visitors to the websites that use its services.

When we contacted the firm last month to ask how it does this, Allen Abbott, NaviStone’s chief operating officer, said by phone that talking about how its technology works is “problematic.”

“A lot of our competitors would love to know how we made it work,” Abbott said. “We have an advantage that we would be silly to reveal.”

We asked whether the company had thought about the privacy implications involved in identifying people visiting a website for sensitive reasons, and whether there were certain customers the company wouldn’t work with.

“Our business is almost entirely e-commerce, helping retailers sell to their customers,” he said. “There was one site that came into our radar that was adult-related material that we decided not to pursue.”

We then described what Acurian does.

“We don’t work with anyone like that,” he said.

We explained that the call was because we’d found NaviStone’s code on AcurianHealth sites.

“It’s possible,” he then said. “We have a lot of customers.”

But Abbott insisted that NaviStone had found a “privacy compliant way” to identify anonymous website visitors—again saying he couldn’t describe it because it was a proprietary technology.

When we analyzed the NaviStone code on Acurian’s sites, we found one way that NaviStone’s technology works: It collects information as soon as it is entered into the text boxes on forms, before the person actually agrees to submit it. When we typed a test email address in the “Join Us” page on Acurian’s site, it was immediately captured and sent to the company’s servers, even if we later chose to close the page without hitting the “Send” button on the form.

In fact, the information was collected before we got to the part of the form that said, “Your privacy is important to us. By selecting this box, you agree to our Privacy Policy and Terms of Use, and agree that we contact you by phone using automated technology or other means using the information you provided above regarding research studies.” – Gizmodo

But that was long ago in terms of technological progress.

However, the methods persist in 2021, an US local tv station reveals that exactly the same scenario occurred in Cincinnati, with the same company at the center of the scandal. Here’s what they’ve just published:

<<Nancy Brashear opened her mail at her Campbell County, Kentucky, home to find an offer to earn money if she joined a COVID-19 vaccine test.

“I got a letter from Acurian Health looking for volunteers for a COVID vaccine study, promising up to $1,200 if you participate or volunteer,” she said.

It looked promising, but Brashear said she started to wonder how they knew she would be a good candidate for a vaccine trial. Did someone with a hospital, doctor’s office or pharmacy sell her health information?

“How do they get my information?” Brashear said. “That really bothers me.”

We called and emailed Acurian Health to find out how they got her name, but did not hear back.

Company is a data firm, not a testing center

Acurian is a legitimate company, according to the Better Business Bureau, and states it is a data firm that connects people with medical trials.

It does not do the actual testing.

“Where did they get this information?” Brashear asked. “HIPPA laws make your history private.”

The Protect Patients Blog has an in-depth article of how Acurian learns if you are a good candidate for a medical trial.

But Brashear found that if you decide to apply, you will then have to give much more medical information to see if you actually qualify. There is no guarantee you will be accepted for a trial, and no guarantee you will earn anything close to $1,200.

“If you go on the website, you have to go through steps to do that, so they are looking for information,” she said.

In the end, she said thanks, but no thanks, wondering if she would be sharing too much medical and personal information with a company she knew little about.

If you want to sign up for a COVID-19 trial, the NIH, National Institutes of Health, is a government site that lists all the authorized vaccine trials going on.

Many of them will pay money, typically a few hundred dollars. However, they may not cover treatment for any side effects.

So be sure to read all the fine print, so you don’t waste your money.>> – WCPO

Also let’s recall our October 2020 article: CONTACT-TRACING DATA HARVESTED FROM PUBS AND RESTAURANTS BEING SOLD ON

I don’t know about you, but what I’ve learned so far is:

  1. Pharmafia still does whatever it takes to get what it wants, even primitive hacking as described above.
  2. These methods are still too primitive for the biggest actors in Pharmafia who are well into artificial intelligence and cutting edge technologies

So what are these top cats doing then?
I’ve consulted some of my insider sources, put it together with my own digs and, as per usual with these creatures, the most obvious suspicions are also true.

If you’ve been around, you should be aware by now of three tendencies that are one, actually:


1. Big Tech and Big Pharma are merging

2. Healthcare and Big Data are merging

They’re not only after health data, don’t worry, all data helps a sale


3. The above are merging with media and the elected government

What are Google and Facebook selling, in fact?
Your data.
What for?
So you can be best manipulated by different interests, with custom-design ads and policies.

Oracle’s National Electronic Health Records Cloud dates back to the beginnings of the COVID-19 pandemic. In March 2020, a couple of weeks after letting President Trump use his estate near Palm Springs for a $100,000-a-plate golfing fundraiser, Ellison placed a call to the White House. According to a Forbes cover story on Ellison, he “asked Trump if a clearinghouse existed for real-time data about treatment efficacies and outcomes.”

Within a week after the president asked “how much?” and Ellison said, “for free,” the tech titan had brought together a team of Oracle engineers “to build a database and website registering coronavirus cases” and work with the National Institutes of Health (NIH), U.S. Food and Drug Administration (FDA) and other agencies.

The first public acknowledgment of Oracle’s progress came on July 3, 2020, when the NIH’s National Institute for Allergies and Infectious Diseases (NIAID), overseen by Dr. Anthony Fauci, launched the COVID-19 Prevention Trials Network (COVPN), aimed at enrolling thousands of volunteers in large-scale trials for a variety of investigational vaccines and monoclonal antibodies.

Fauci achieved this by merging four existing networks, all researching HIV/AIDS, something they would continue to do. “The network is expected to operate more than 100 clinical trial sites across the United States and internationally,” according to the NIAID press release which also stated “the COVPN website features a customized data collection platform, which Oracle (Redwood Shores, CA) built and donated, to securely identify potential trial participants.”

In August, a paper published by the Johns Hopkins Center for Health Security proposed that the “passive reporting” systems managed by the CDC and FDA ought to be revamped to forge “an active safety surveillance system directed by the CDC that monitors all [COVID-19] vaccine recipients — perhaps by short message service or other electronic mechanisms.”

By September, Operation Warp Speed director Moncef Slaoui was telling the periodical Science: “We’re working super hard on a very active pharmacovigilance system, to make sure that when the vaccines are introduced that we’ll absolutely continue to assess their safety.

In October, Slaoui told the New York Times: “The FDA is proposing that at least 50% of the individuals in the study population have at least two months of follow-up on safety before the vaccines are approved. And secondly, we are working really hard with the FDA and the CDC to make sure we have a very active pharmacovigilance surveillance system to allow us to continue to assess the safety of the vaccines as they are being used in the high risk population.”

And the Wall Street Journal reported in a profile of Slaoui that he’d said “tracking systems will have to be ‘incredibly precise’ to ensure that patients each get two doses of the same vaccine and to monitor them for adverse health effects. Operation Warp Speed has selected the medical-distribution company McKesson and cloud operators Google and Oracle to collect and track vaccine data.”

“This marked the first time that Oracle’s role was revealed to have expanded to include Operation Warp Speed.

Oracle Chairman Ellison’s lucrative government arrangements trace back to the data software pioneer’s origins. In 1975, then in his early thirties, Ellison worked on a project for the electronics company Ampex in the Bay area, building a large terabit memory system for the CIA.

Ellison revealed in 2014 that the CIA not only became his firm’s first customer for a “relational database” two years later, but that he adopted the name from a CIA project called Oracle. “The news about our hot little database traveled around the intelligence community pretty quickly,” Ellison was quoted as saying in the 2003 book, “Softwar.” “In a little over six months’ time we had won several deals — the CIA, Navy Intelligence, Air Force Intelligence and the NSA [National Security Agency].” – Technocracy News

From this industry’s perspective, you enrolling KFC’s Fidelity Club or a vaccine trial is the same technical challenge. One that they keep winning lately.

Remember when the sister of YouTube’s CEO and former wife of Google’s founder Sergey Brin, still a business partner, set up a DNA testing company and then sold the data for $300 million to pharma giant genocidal company GSK?

Source

Oh, it’s all about science and health, sure, but what science and whose health?
Because anyone who’s been in touch with reality lately knows a few more things:
– Pharmafia invests much more in the science of marketing than in medical sciences
– That data often comes from marketing experts such as Google and Facebook
– Marketing and propaganda sell and persuade much more efficiently than science when it comes to large masses of people. Or all of them. It’s way easier and cheaper to manipulate the low-IQ majority than to heal it. Especially with these tools Big Tech brought aboard.

What keeps them from finding and manipulating the feeble minds they need for these new atrocities they call “vaccines human trials” and, in fact, are neither vaccines or human, just deranged human abuse experimentation?
From what I’ve found out so far, the answer is: nothing.
Everything you type on your computer is collected and can be processed to obtain a method to target and determine people to subject their kids to this. It’s probably much easier to sell than some of their other products. This is already a massive industry that often breaks ethical and even legal barriers.

Source: The Guardian


What, you’ve never thought Cambridge Analytica can work for Pharmafia too?
Well then remember we’ve passed that, Facebook, Amazon, Microsoft (recording my typing right now) and Alphabet (Google) are not distinguishable from Pharmafia at all. The concept that they wouldn’t take any and all advantage of their new powers and domination is comically delirious.
Moderna must be running out of money or love if Google won’t send them a mere 3000 kids, no joke.

We are funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

I mean it. Here’s how:

Internalize the realization that the longer this crisis goes, the shorter and unhappier our lives will be and most people are already on the edge, many crossed the edge already. We needed to push yesterday, but ok, we didn’t and we’re here now, let’s do it now!

CLICK HERE to find the list of World Economic Forum members.

You will find all Western covid vaccines manufacturers on the market right now.

Defund, deride and dismantle these genocidal cartels by any means available. There’s plenty of efficient legal means to sink them, no need to get the establishment’s hoodlums on your back by pushing the law.

You can cancel many of them simply by voting with your dollars and your (lack of) positive attention.
Yeah, nothing more revolutionary than doing things right out of your own conscience!

Spread this message / video, download, reupload, make your own, it doesn’t matter.

Wherever you see these dipshits on internet, downvote them, block them, and drop them the headline of this article in a comment.
Attention! Don’t use other hashtags that can be censored, blacking out all our effort in bulk, these hashtags are theirs, they are secure and the best vehicle for the message.
On platforms like Facebook and Youtube most comments containing un-friendly links are censored, so there maybe it works better without a link, maybe you can upload the cover photo or the video instead.

Teach others the power and the utmost importance of this boycott, while we can still choose what we do with our resources and attention! It’s one of our last and most powerful weapons.

CAN YOU AFFORD ANY MORE OF THIS?

If I get any more good ideas along this line, I’ll update this article. For now I’m ruminating on a Logo / T-Shirt design for this, suggestions welcome on my socials, see the links tab in the upper menu of this website, thank you!

We are funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Klaus Schwab, a Rothschild puppet

Many people have problems or fall lazy following their money trail.
Maybe they can at least follow their loud and clear words.

“Stakeholder Capitalism”, one of Klaus Schwab’s many buzzwords, is what expects us at the end of The Great Reset or The Fourth Industrial Revolution, according to its main ideologists.

It’s that stage where “you own nothing and you are happy” or you are on government’s kill list.

If the line between communism and fascism appears blurred many times, it’s because it is. And Stakeholder Capitalism totally erases it.

And who’s going to be at the top of the pyramid of the new centralized global system pushed by the social parasites from the World Economic Forum?

Any road I take, it takes me same place.

Also read:

We are funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them